1. Twist1 Plays an Anti-apoptotic Role in Mutant Huntingtin Expression Striatal Progenitor Cells
   Wei-Ping Jen et al, 2020, Molecular Neurobiology CrossRef
2. The relationship between EMT, CD44high/EGFRlow phenotype, and treatment response in head and neck cancer cell lines
   Ann‐Charlotte Johansson et al, 2016, Journal of Oral Pathology & Medicine CrossRef
3. ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma
   Aishah Nasir et al, 2021, Neuro-Oncology Advances CrossRef
4. Implications of cancer stem cells in developing therapeutic resistance in oral cancer
   Prajna Paramita Naik et al, 2016, Oral Oncology CrossRef
5. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
   Till Jasper Meyer et al, 2021, International Journal of Molecular Sciences CrossRef
6. Angiotensin Inhibition, TGF-β and EMT in Cancer
   Fabian Bernhard Pallasch et al, 2020, Cancers CrossRef
7. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT
   Rong Li et al, 2018, International Journal of Oncology CrossRef
8. The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential
   Juanjing Wang et al, 2024, Discover Oncology CrossRef
9. Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity
   SUMEI LU et al, 2016, Oncology Reports CrossRef
10. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer
    Yong Yang et al, 2017, International Journal of Oncology CrossRef
11. Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
    Jente van Staalduinen et al, 2018, Oncogene CrossRef
12. Bcl-2 overexpression contributes to laryngeal carcinoma cell survival by forming a complex with Hsp90β
    Sai Li et al, 2017, Oncology Reports CrossRef
13. A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer
    Yue Wang et al, 2024, Medicine CrossRef
14. Non-coding RNAs in drug resistance of head and neck cancers: A review
    Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
15. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
    Sima Ardalan Khales et al, 2022, BMC Cancer CrossRef
16. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo et al, 2021, Archives of Pharmacal Research CrossRef
17. A non-proliferative role of pyrimidine metabolism in cancer
    Aarif Siddiqui et al, 2020, Molecular Metabolism CrossRef
18. RBM24 Mediates Lymph Node Metastasis and Epithelial-Mesenchymal Transition in Human Hypopharyngeal Squamous Cell Carcinoma by Regulating Twist1
    Yuhong Liu et al, 2022, Journal of Oncology CrossRef
19. Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers
    Marta Pawlicka et al, 2024, Cancers CrossRef